Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 308


Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.

Jakobsen L, Niemann T, Thorsgaard N, Thuesen L, Lassen JF, Jensen LO, Thayssen P, Ravkilde J, Tilsted HH, Mehnert F, Johnsen SP.

Circ Cardiovasc Interv. 2012 Oct;5(5):641-8. doi: 10.1161/CIRCINTERVENTIONS.112.968271. Epub 2012 Oct 2.


Interaction between income and education in predicting long-term survival after acute myocardial infarction.

Gerber Y, Goldbourt U, Drory Y; Israel Study Group on First Acute Myocardial Infarction.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):526-32. doi: 10.1097/HJR.0b013e328304feac.


Ethnicity and long-term prognosis after myocardial infarction: a population-based cohort study.

Nakash O, Gerber Y, Goldbourt U, Benyamini Y, Drory Y; Israel Study Group on First Acute Myocardial Infarction.

Med Care. 2013 Feb;51(2):137-43. doi: 10.1097/MLR.0b013e318270bab5.


Sex-specific outcomes of diabetic patients with acute myocardial infarction who have undergone percutaneous coronary intervention: a register linkage study.

Blöndal M, Ainla T, Marandi T, Baburin A, Eha J.

Cardiovasc Diabetol. 2012 Aug 11;11:96. doi: 10.1186/1475-2840-11-96.


High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.

Herrmann J, Lennon RJ, Barsness GW, Sandhu GS, Gulati R, Best PJ, Sorajja P, Bresnahan JF, Mathew V, Bell MR, Prasad A.

Circ Cardiovasc Interv. 2012 Dec;5(6):783-90. doi: 10.1161/CIRCINTERVENTIONS.112.972182. Epub 2012 Dec 4.


Socioeconomic disparities in outcomes after acute myocardial infarction.

Bernheim SM, Spertus JA, Reid KJ, Bradley EH, Desai RA, Peterson ED, Rathore SS, Normand SL, Jones PG, Rahimi A, Krumholz HM.

Am Heart J. 2007 Feb;153(2):313-9.


Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry.

Lee HW, Hong TJ, Yang MJ, An SG, Oh JH, Choi JH, Lee HC, Cha KS, Hong JY; Korea Acute Myocardial Infarction Registry Investigators.

Cardiol J. 2012;19(3):256-66.


Assessment of the relation between IVUS measurements and clinical outcome in elderly patients after sirolimus-eluting stent implantation for de novo coronary lesions.

Du R, Zhang RY, Zhang Q, Shi YH, Hu J, Yang ZK, Ding FH, Zhang JS, Shen WF.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1653-62. doi: 10.1007/s10554-011-0007-z. Epub 2012 Jan 6.


Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.

Ndrepepa G, Neumann FJ, Deliargyris EN, Mehran R, Mehilli J, Ferenc M, Schulz S, Schömig A, Kastrati A, Stone GW.

Circ Cardiovasc Interv. 2012 Oct;5(5):705-12. doi: 10.1161/CIRCINTERVENTIONS.112.972869. Epub 2012 Oct 9.


Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS.

Hess CN, McCoy LA, Duggirala HJ, Tavris DR, O'Callaghan K, Douglas PS, Peterson ED, Wang TY.

J Am Heart Assoc. 2014 Feb 7;3(1):e000523. doi: 10.1161/JAHA.113.000523.


Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database.

Jones DA, Gallagher S, Rathod KS, Redwood S, de Belder MA, Mathur A, Timmis AD, Ludman PF, Townend JN, Wragg A; NICOR (National Institute for Cardiovascular Outcomes Research).

JACC Cardiovasc Interv. 2014 Apr;7(4):362-71. doi: 10.1016/j.jcin.2013.11.013.


The association of socioeconomic status with three-year clinical outcomes in patients with acute myocardial infarction who underwent percutaneous coronary intervention.

Kim JH, Jeong MH, Park IH, Choi JS, Rhee JA, Lee DH, Park SH, Kim IS, Jeong HC, Cho JY, Jang SY, Lee KH, Park KH, Sim DS, Kim KH, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC.

J Korean Med Sci. 2014 Apr;29(4):536-43. doi: 10.3346/jkms.2014.29.4.536. Epub 2014 Apr 1.


Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention.

Seo SM, Kim TH, Kim CJ, Hwang BH, Kang MK, Koh YS, Min J, Chang K, Kim PJ, Park HJ, Chung WS, Jeong MH, Kim YJ, Park SJ, Seung KB; Korean Acute Myocardial Infarction Registry Investigators.

Coron Artery Dis. 2012 Aug;23(5):307-14. doi: 10.1097/MCA.0b013e3283519f25.


High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention.

Bjerre M, Pedersen SH, Møgelvang R, Lindberg S, Jensen JS, Galatius S, Flyvbjerg A.

Eur J Prev Cardiol. 2013 Dec;20(6):922-9. doi: 10.1177/2047487313487083. Epub 2013 Apr 23.


Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.

Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Pagliuca MR, Stanco G, Rosato G, De Luca G.

Circulation. 2009 Sep 15;120(11):964-72. doi: 10.1161/CIRCULATIONAHA.108.830372. Epub 2009 Aug 31. Retraction in: Circulation. 2010 Mar 2;121(8):e228.


Prognostic utility of neutrophil gelatinase-associated lipocalin in predicting mortality and cardiovascular events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Lindberg S, Pedersen SH, Mogelvang R, Jensen JS, Flyvbjerg A, Galatius S, Magnusson NE.

J Am Coll Cardiol. 2012 Jul 24;60(4):339-45. doi: 10.1016/j.jacc.2012.04.017.


Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions.

Ortolani P, Solinas E, Guastaroba P, Marino M, Casella G, Manari A, Piovaccari G, Ottani F, Varani E, Campo G, Marzocchi A, Merlini PA, Caminiti C, De Palma R, Ardissino D.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):421-9. doi: 10.2459/JCM.0b013e328357bb04.


Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.

Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-2005).

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):41-9. doi: 10.1002/ccd.22533.


Outcomes after unrestricted use of everolimus-eluting and sirolimus-eluting stents in routine clinical practice: a multicenter, prospective cohort study.

Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Her SH, Hur SH, Park JS, Kim MK, Choi YS, Kim HS, Cho JH, Lee SG, Park YW, Jeong MH, Lee BK, Lee NH, Lim DS, Yoon J, Seung KB, Shin WY, Rha SW, Kim KS, Tahk SJ, Park BE, Ahn T, Yang JY, Jeong YS, Rhew JH, Park SJ; IRIS-DES Investigators.

Circ Cardiovasc Interv. 2012 Jun;5(3):365-71. doi: 10.1161/CIRCINTERVENTIONS.111.966549. Epub 2012 Jun 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk